Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer
- Supplementary File 1:
PDF-Document (PDF, 451 KiB)
Ci, L.-q.; Huang, Z.-g.; Lv, F.-m.; Wang, J.; Feng, L.-l.; Sun, F.; Cao, S.-j.; Liu, Z.-p.; Liu, Y.; Wei, G.; Lu, W.-y. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15. https://doi.org/10.3390/pharmaceutics11010015
Ci L-q, Huang Z-g, Lv F-m, Wang J, Feng L-l, Sun F, Cao S-j, Liu Z-p, Liu Y, Wei G, Lu W-y. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics. 2019; 11(1):15. https://doi.org/10.3390/pharmaceutics11010015
Chicago/Turabian StyleCi, Li-qian; Huang, Zhi-gang; Lv, Feng-mei; Wang, Jun; Feng, Ling-lin; Sun, Feng; Cao, Shui-juan; Liu, Zhe-peng; Liu, Yu; Wei, Gang; Lu, Wei-yue. 2019. "Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer" Pharmaceutics 11, no. 1: 15. https://doi.org/10.3390/pharmaceutics11010015